Correlation between rises in Chlamydia pneumoniae-specific antibodies, platelet activation and lipid peroxidation

H Kälvegren1, J Fridfeldt, P Garvin

  • 1Department of Medicine and Health, Faculty of Health Sciences, Linköping University, 581 85, Linköping, Sweden. hanka@imv.liu.se

Insights

Percutaneous coronary intervention (PCI) may release Chlamydia pneumoniae from atherosclerotic lesions, activating platelets and causing lipid peroxidation. This study investigated the link between PCI, C. pneumoniae infection, and cardiovascular risk markers.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Biochemistry

Background:

  • Chlamydia pneumoniae (C. pneumoniae) is known to activate platelets and oxidize low-density lipoproteins in vitro.
  • The potential release of C. pneumoniae during percutaneous coronary intervention (PCI) and its subsequent effects on platelet activation and lipid peroxidation remain under investigation.

Purpose of the Study:

  • To determine if C. pneumoniae is released during PCI.
  • To investigate the association between C. pneumoniae release, platelet activation, and lipid peroxidation following PCI.

Main Methods:

  • Serum C. pneumoniae IgA and IgG antibodies, serotonin, and lipid peroxidation were measured in 73 patients undergoing PCI/CABG and 57 controls.
  • Measurements were taken before and at 24 hours, 1 month, and 6 months after angiography.

Main Results:

  • Patients undergoing PCI/CABG showed significantly higher serum C. pneumoniae IgA concentrations than controls.
  • In 38% of C. pneumoniae IgG-positive patients, IgG levels increased 1 month post-PCI.
  • Elevated C. pneumoniae IgG 1 month post-PCI correlated strongly with increased plasma lipid peroxidation (r=0.91) and platelet-derived serotonin (r=0.62).

Conclusions:

  • PCI treatment for coronary stenosis appears to release C. pneumoniae from atherosclerotic lesions.
  • This release is associated with subsequent platelet activation and lipid peroxidation, suggesting a potential mechanism for cardiovascular events post-PCI.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...